Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Kyuchukov, N. Yanev, Z. Ivanova, P. Pavlov, P. Glogovska, T. Popova, I. Krachunov, Y. Ivanov (Pleven, Bulgaria). COPD comorbidities and risk assessment according to GOLD 2011 revision. Eur Respir J 2013; 42: Suppl. 57, 4185

Member's Comments

No comment yet.

Related content which might interest you: High risk COPD patients cost less if treated according to GOLD 2011 recommendations Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Evaluation of the GOLD 2011 severity criteria across the COPD spectrum Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Three year follow-up of distribution and stability of patients with COPD according GOLD 2014 Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 The BODE index predicts mortality better than 2007 GOLD and GOLD ABCD Source: International Congress 2014 – COPD exacerbations Year: 2014 Comparison of 2011 and 2007 GOLD guidelines for predicting mortality and hospitalization Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 New GOLD recommendations in a seven years follow up - changes in symptoms and risk categories Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care Year: 2013 COPD: GOLD 2011 and implications for clinical practice Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Impact of comorbidities in COPD prognosys scores Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 GOLD and phenotypes: The new Czech COPD guidelines Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 GOLD staging and grading for predicting one-year mortality in COPD patients with severe exacerbation Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Outcomes in patients with COPD during a 3 year follow-up Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 2 years in the life of COPD patients: Evolution of GOLD 2011 classification in the ’real-life’ DACCORD study Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Change in the COPD assessment test (CAT) score as predictor of short-term evolution of patients admitted for an exacerbation of COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014 Mortality and readmissions in patients with severe COPD. Validation of the CODEX index Source: International Congress 2015 – Best abstracts in COPD management Year: 2015 Implementation of COPD phenotypes in real life Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Does the 2011 GOLD staging of COPD reflect phenotype and severity of the disease as assessed by CT? Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Comparing the 2007 and 2011 GOLD classifications as predictors of all-cause mortality and morbidity in COPD Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 COPD severity analysis according to current evaluation criteria – National survey Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Outcomes of COPD exacerbations - a report from the ERS COPD audit in Austria Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Comparing quality measures during hospitalization for chronic obstructive pulmonary disease in 2005-06 and 2010 Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014